Young E Whang MD
Genitourinary Oncology
Associate Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
101 Manning DrChapel Hill, NC 27514
Phone+1 984-974-0000
Fax+1 919-966-7772
Dr. Whang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ronald Reagan UCLA Medical CenterPost-Doctoral Fellowship, 1996 - 1998- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990, MD
Certifications & Licensure
NC State Medical License 1998 - 2026
CA State Medical License 1991 - 1998
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
- Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2012 Mar 30
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsReal-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer.Brian Lam, Jo E Rodgers, Benyam Muluneh, Darrian Proco, Young E Whang
The Annals of Pharmacotherapy. 2024-10-01 - 6 citationsAbiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).Maha Hussain, Masha Kocherginsky, Neeraj Agarwal, Nabil Adra, Jingsong Zhang
Clinical Cancer Research. 2024-10-01 - 2 citationsTarlatamab for Large Cell Neuroendocrine Carcinoma in a Young Adult: A Case Report.Shetal A Patel, Young Whang, Chaely Medley, Kevin Chen, Jasmine Jordan
JTO Clinical and Research Reports. 2024-10-01
Journal Articles
- Article ZFX Mediates Non-Canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate CancerYoung Whang, MD, ScienceDirect
Grant Support
- Regulation Of Androgen Receptor By HER-2 And Ack1 Tyrosine KinasesNational Cancer Institute2008–2012
- Functional Analysis Of PTEN In Prostate CancerNational Cancer Institute2000–2005
- Targeted Therapy Of Prostate CancerNational Cancer Institute2003–2004
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
